This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.

This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.

This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.